Indraprastha Medical Corporation Intrinsic Value

Indraprastha Medical Corporation intrinsic value. Indraprastha Medical Corporation (INDRAMEDCO) median intrinsic value is ₹333.91 from 10 valuation models (range ₹160–₹460), vs current price ₹360.35 — -7.3% downside (Trading Near Calculated Value), margin of safety -7.9%. For current market price and key ratios, visit Indraprastha Medical Corporati share price today.

Market Price (CMP)
₹360.35
Primary Intrinsic Value
₹459.80
Market Cap
₹3315 Cr
-7.3% Downside
Median Value
₹333.91
Value Range
₹160 - ₹460
Assessment
Trading Near Calculated Value
Safety Margin
-7.9%

INDRAMEDCO Valuation Methods Summary — DCF, Graham Number & P/E

Indraprastha Medical Corporation intrinsic value across 10 models vs current price ₹360.35 — upside/downside and value range per method. Analyse INDRAMEDCO shareholder distribution to track promoter, FII and institutional holdings.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹459.80 ₹367.84 - ₹551.76 +27.6% EPS: ₹20.90, Sector P/E: 22x
Book Value Method asset ₹160.87 ₹144.78 - ₹176.96 -55.4% Book Value/Share: ₹80.43, P/B: 2.0x
Revenue Multiple Method revenue ₹345.00 ₹310.50 - ₹379.50 -4.3% Revenue/Share: ₹172.50, P/S: 2.0x
EBITDA Multiple Method earnings ₹338.04 ₹304.24 - ₹371.84 -6.2% EBITDA: ₹311.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹246.57 ₹197.26 - ₹295.88 -31.6% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹334.40 ₹300.96 - ₹367.84 -7.2% EPS Growth: 20.0%, Fair P/E: 16.0x
Growth Adjusted P/E growth ₹328.19 ₹295.37 - ₹361.01 -8.9% Revenue Growth: 9.4%, Adj P/E: 15.7x
ROE Based Valuation profitability ₹333.91 ₹300.52 - ₹367.30 -7.3% ROE: 25.9%, P/E Multiple: 16x
Graham Defensive Method conservative ₹160.87 ₹144.78 - ₹176.96 -55.4% EPS: ₹20.90, BVPS: ₹80.43
Dividend Yield Method dividend ₹160.00 ₹144.00 - ₹176.00 -55.6% DPS: ₹4.00, Target Yield: 2.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

INDRAMEDCO Intrinsic Value vs Market Price — All Valuation Models

Indraprastha Medical Corporation fair value range ₹160–₹460 vs current market price ₹360.35 across 10 valuation models. Browse INDRAMEDCO annual financials for revenue, profit, balance sheet and cash flow data.

INDRAMEDCO Intrinsic Value Analysis — Undervalued or Overvalued?

Indraprastha Medical Corporation median intrinsic value ₹333.91, current price ₹360.35 — Trading Near Calculated Value by 7.3%, margin of safety -7.9%.

What is the intrinsic value of INDRAMEDCO?

Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Indraprastha Medical Corporation (INDRAMEDCO) is ₹333.91 (median value). With the current market price of ₹360.35, this represents a -7.3% variance from our estimated fair value.

The valuation range spans from ₹160.00 to ₹459.80, indicating ₹160.00 - ₹459.80.

Is INDRAMEDCO undervalued or overvalued?

Based on our multi-method analysis, Indraprastha Medical Corporation (INDRAMEDCO) appears to be trading near calculated value by approximately 7.3%.

INDRAMEDCO Financial Health — Key Ratios vs Industry Benchmarks

Indraprastha Medical Corporation financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 25.9% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 18.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 1.60x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

INDRAMEDCO Cash Flow Quality — Operating & Free Cash Flow

Indraprastha Medical Corporation operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹167 Cr ₹78 Cr Positive Free Cash Flow 7/10
March 2025 ₹157 Cr ₹102 Cr Positive Free Cash Flow 8/10
March 2024 ₹200 Cr ₹121 Cr Positive Free Cash Flow 8/10
March 2023 ₹145 Cr ₹91 Cr Positive Free Cash Flow 8/10
March 2022 ₹94 Cr ₹57 Cr Positive Free Cash Flow 8/10